Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Effect of N-methylformamide on radiocurability of murine tumors

Journal Article · · Radiat. Res.; (United States)
DOI:https://doi.org/10.2307/3577192· OSTI ID:5379927
N-Methylformamide (NMF) is a polar solvent with maturational activity, i.e., it induces malignant cells to form more differentiated phenotypes. In addition, it renders tumor cells more sensitive to chemotherapeutic drugs and ionizing radiation. In the present study, NMF failed to augment radiocurability, as measured by the single-dose TCD50 assay, of two murine tumors: an 8-mm fibrosarcoma (FSA) and a 6-mm mammary carcinoma (MCA-K). NMF, at a dose of 300 mg/kg, was given ip daily for several days before and/or after local tumor irradiation.
Research Organization:
Univ. of Texas, M. D. Anderson Hospital and Tumor Institute, Houston (USA)
OSTI ID:
5379927
Journal Information:
Radiat. Res.; (United States), Journal Name: Radiat. Res.; (United States) Vol. 113:1; ISSN RAREA
Country of Publication:
United States
Language:
English